Case Number 6791
Request Date 18/06/2019
Completion Date 11/11/2019

 

Details of the Request

  1. Please confirm or deny if Ashford and St. Peter's Hospitals NHS Foundation Trust holds information on the number of people diagnosed in Ashford and St. Peter's Hospitals NHS Foundation Trust with early breast cancer in each year from 2013 to 2018. If confirm, please release this data.
  2. Please confirm or deny if ASPH holds information on the number of people diagnosed in ASPH with early breast cancer that were offered tumour profiling tests to guide adjuvant chemotherapy decisions, in each year from 2013 to 2018. If confirm, please release this data.
  3. Please confirm or deny if ASPH holds information on the number of people diagnosed in ASPH with early breast cancer that were tested with tumour profiling tests to guide adjuvant chemotherapy decisions, in each year from 2013 to 2018. If confirm, please release this data.

 

Details of the Response

1. Please confirm or deny if Ashford and St. Peter's Hospitals NHS Foundation Trust holds information on the number of people diagnosed in Ashford and St. Peter's Hospitals NHS Foundation Trust with early breast cancer in each year from 2013 to 2018.

Yes

 

If confirm, please release this data.

The Trust holds the requested information, but considers it is exempt under section 12 of the Act, as the cost of compliance is estimated to exceed the appropriate limit.

The Trust can provide the number of new breast cancer diagnosis but to identify those with early breast cancer will require individual clinical review.

 

2. Please confirm or deny if Ashford and St. Peter's Hospitals NHS Foundation Trust holds information on the number of people diagnosed in Ashford and St. Peter's Hospitals NHS Foundation Trust with early breast cancer that were offered tumour profiling tests to guide adjuvant chemotherapy decisions, in each year from 2013 to 2018.

Yes

 

If confirm, please release this data.

The Trust holds the requested information, but considers it is exempt under section 12 of the Act, as the cost of compliance is estimated to exceed the appropriate limit. Please see reason above.

 

3. Please confirm or deny if Ashford and St. Peter's Hospitals NHS Foundation Trust holds information on the number of people diagnosed in Ashford and St. Peter's Hospitals NHS Foundation Trust with early breast cancer that were tested with tumour profiling tests to guide adjuvant chemotherapy decisions, in each year from 2013 to 2018.

Yes

 

If confirm, please release this data.

The Trust holds the requested information, but considers it is exempt under section 12 of the Act, as the cost of compliance is estimated to exceed the appropriate limit. Please see reason above.

 

4. Please confirm or deny if Ashford and St. Peter's Hospitals NHS Foundation Trust holds information on the number of people diagnosed in Ashford and St. Peter's Hospitals NHS Foundation Trust with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative and lymph node (LN)-negative (including micrometastatic disease) early breast cancer in each year from 2013 to 2018.

Yes

 

If confirm, please release this data.

The Trust holds the requested information, but considers it is exempt under section 12 of the Act, as the cost of compliance is estimated to exceed the appropriate limit. Please see reason above.

 

5. Please confirm or deny if Ashford and St. Peter's Hospitals NHS Foundation Trust holds information on the numbers of people diagnosed in Ashford and St. Peter's Hospitals NHS Foundation Trust with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative and lymph node (LN)-negative (including micrometastatic disease) early breast cancer that were offered tumour profiling tests to guide adjuvant chemotherapy decisions in each year from 2013 to 2018.

Yes

 

If confirm, please release this data.

The Trust holds the requested information, but considers it is exempt under section 12 of the Act, as the cost of compliance is estimated to exceed the appropriate limit. Please see reason above.

 

6. Please confirm or deny if Ashford and St. Peter's Hospitals NHS Foundation Trust holds information on the number of people diagnosed in Ashford and St. Peter's Hospitals NHS Foundation Trust with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative and lymph node (LN)-negative (including micrometastatic disease) early breast cancer that were tested with tumour profiling tests to guide adjuvant chemotherapy decisions in each year from 2013 to 2018.

Yes

 

If confirm, please release this data.

The Trust holds the requested information, but considers it is exempt under section 12 of the Act, as the cost of compliance is estimated to exceed the appropriate limit. Please see reason above.